July 29, 2019 / 04:55 PM IST
Reported Standalone quarterly numbers for Sun Pharma Advanced Research Company are:Net Sales at Rs 17.32 crore in June 2019 up 3.03% from Rs. 16.81 crore in June 2018.
Story continues below Advertisement
Quarterly Net Loss at Rs. 94.19 crore in June 2019 down 46.08% from Rs. 64.48 crore in June 2018.
EBITDA stands negative at Rs. 91.35 crore in June 2019 down 46.02% from Rs. 62.56 crore in June 2018.
Sun Pharma Adv shares closed at 165.05 on July 26, 2019 (NSE) and has given -0.69% returns over the last 6 months and -54.38% over the last 12 months.
Sun Pharma Advanced Research Company | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'19 | Mar'19 | Jun'18 | Net Sales/Income from operations | 17.32 | 84.83 | 16.81 | Other Operating Income | -- | -- | -- | Total Income From Operations | 17.32 | 84.83 | 16.81 | EXPENDITURE | Consumption of Raw Materials | 10.14 | 2.99 | 2.88 | Purchase of Traded Goods | -- | -- | -- | Increase/Decrease in Stocks | -- | -- | -- | Power & Fuel | -- | -- | -- | Employees Cost | 22.67 | 19.33 | 20.43 | Depreciation | 2.25 | 1.82 | 1.90 | Excise Duty | -- | -- | -- | Admin. And Selling Expenses | -- | -- | -- | R & D Expenses | -- | -- | -- | Provisions And Contingencies | -- | -- | -- | Exp. Capitalised | -- | -- | -- | Other Expenses | 79.53 | 74.43 | 57.29 | P/L Before Other Inc. , Int., Excpt. Items & Tax | -97.27 | -13.74 | -65.69 | Other Income | 3.67 | 4.43 | 1.23 | P/L Before Int., Excpt. Items & Tax | -93.60 | -9.31 | -64.46 | Interest | 0.59 | 0.04 | 0.02 | P/L Before Exceptional Items & Tax | -94.19 | -9.35 | -64.48 | Exceptional Items | -- | -- | -- | P/L Before Tax | -94.19 | -9.35 | -64.48 | Tax | -- | -- | -- | P/L After Tax from Ordinary Activities | -94.19 | -9.35 | -64.48 | Prior Year Adjustments | -- | -- | -- | Extra Ordinary Items | -- | -- | -- | Net Profit/(Loss) For the Period | -94.19 | -9.35 | -64.48 | Equity Share Capital | 26.21 | 26.21 | 25.09 | Reserves Excluding Revaluation Reserves | -- | -- | -- | Equity Dividend Rate (%) | -- | -- | -- | EPS Before Extra Ordinary | Basic EPS | -3.59 | -0.37 | -2.57 | Diluted EPS | -3.59 | -0.37 | -2.57 | EPS After Extra Ordinary | Basic EPS | -3.59 | -0.37 | -2.57 | Diluted EPS | -3.59 | -0.37 | -2.57 | Public Share Holding | No Of Shares (Crores) | -- | -- | -- | Share Holding (%) | -- | -- | -- | Promoters and Promoter Group Shareholding | a) Pledged/Encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | b) Non-encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | Source : Dion Global Solutions Limited |
|
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!